Cerus (CERS) Change in Receivables (2010 - 2026)
Cerus (CERS) reported Change in Receivables of -$869000.0 for Q1 2026, up 76.26% on a YoY basis from -$493012.4 in Q1 2025, and down 242.93% sequentially from $608000.0 in Q4 2025.
Cerus (CERS) Change in Receivables (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Change in Receivables data on file, last reported at -$869000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 76.26% year-over-year to -$869000.0; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 13.2% YoY), and the FY2025 full-year result was $396000.0, up 107.19% from the prior year.
- Change in Receivables declined to -$869000.0 in Q1 2026, from $608000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $10.8 million in Q4 2023 to a low of -$12.8 million in Q1 2024.
- A 5-year average of $254411.8 and a median of $608000.0 in 2025 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables soared 396.86% in 2022 and plunged 1723.58% in 2023, its largest moves.
- Tracing CERS's Change in Receivables over 5 years: stood at $6.0 million in 2022, then jumped by 78.86% to $10.8 million in 2023, then tumbled by 47.87% to $5.6 million in 2024, then sank by 89.19% to $608000.0 in 2025, then tumbled by 242.93% to -$869000.0 in 2026.
- Business Quant data shows CERS's Change in Receivables at -$869000.0 in Q1 2026, $608000.0 in Q4 2025, and -$1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn | -124.60 Mn |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn | -141.00 Mn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn | - |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | -869,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -869,000.00 |
| Mar 31, 2026 | -869,000.00 |
| Dec 31, 2025 | 608,000.00 |
| Dec 31, 2025 | 608,000.00 |
| Sep 30, 2025 | -1.44 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Mar 31, 2025 | -3.66 Mn |
| Mar 31, 2025 | -3.66 Mn |
| Dec 31, 2024 | 5.62 Mn |
| Dec 31, 2024 | 5.62 Mn |
| Sep 30, 2024 | 491,000.00 |
| Sep 30, 2024 | 491,000.00 |
| Jun 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | -12.84 Mn |
| Mar 31, 2024 | -12.84 Mn |
| Dec 31, 2023 | 10.79 Mn |
| Dec 31, 2023 | 10.79 Mn |